Myriad Genetics, Inc.MYGNNASDAQ
Loading
EBITDA Margin Over TimeContracting
Percentile Rank0
Studio
Year-over-Year Change

EBITDA as a percentage of revenue

Latest
-48.39%
↓ 387% vs avg
Percentile
P0
Near historical low
Streak
1 yr
Consecutive declineContracting
Average
-9.94%
Historical baseline
PeriodValueYoY Change
TTM-48.39%-581.2%
2024-7.10%+72.9%
2023-26.21%-109.9%
2022-12.49%-801.0%
20211.78%+108.0%
2020-22.15%-0.7%
2019-22.00%-320.3%
20189.99%-31.9%
201714.66%+17.3%
201612.50%-